Skip to content

Drug interactions

Efavirenz + Metformin-repaglinide

Severity: Moderate

Efavirenz and Metformin-repaglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces CYP3A4 and CYP2B6 and may lower repaglinide concentrations, reducing its glucose-lowering effect. The magnitude is uncertain and variable between patients.

What this interaction means in plain words

Efavirenz and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Metformin-repaglinide belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of CYP3A4-mediated metabolism of repaglinide.

What to do

Monitor blood glucose after starting or stopping efavirenz and adjust the repaglinide dose as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Metformin-repaglinide?

MediHelp rates the interaction as moderate. Efavirenz and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz induces CYP3A4 and CYP2B6 and may lower repaglinide concentrations, reducing its glucose-lowering effect. The magnitude is uncertain and variable between patients.

How serious is the interaction between Efavirenz and Metformin-repaglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose after starting or stopping efavirenz and adjust the repaglinide dose as needed.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in